Bone Marrow Disorders Flashcards
Pure Red Cell Aplasia (PRCA)
Pure red cell aplasia (PRCA) or erythroblastopenia refers to a type of anemia affecting the precursors to red blood cells but not to white blood cells, or platelets.
Characterized by a severe reduction in the number of reticulocytes in the peripheral blood and the virtual absence of erythroid precursors in the bone marrow. Often the bone marrow ceases to produce red blood cells.
Pure Red Cell Aplasia (PRCA) Treatment
red cell transfusions for symptomatic anemia
cessation of possible offending drugs
immediate hematologic consultation
Myelophthisic Anemia
Myelophthisic anemia (or myelophthisis) is a severe kind of anemia found in some people with diseases that affect the bone marrow.
Myelophythisis refers to the displacement of hemopoietic bone-marrow tissue into the peripheral blood, either by fibrosis, tumors or granulomas.
Myelodysplastic syndrome (myelodysplasia or MDS)
Heterogeneous group of hematopoietic stem cell disorders characterized by dysplastic and ineffective blood cell production.
Dysplasia of one or more cell lines is the morphologic hallmark of MDS.
AKA “preleukemia” as it has a variable risk of transformation to acute leukemia
Myelodysplastic syndrome (myelodysplasia or MDS) Management
MDS is not known to be curable with conventional Rx such as chemotherapy
Consider transplant in the young, or investigational Rx.
For most patients, treatment is supportive (RBC transfusions, treat infections)
Growth factors, erythropoietin effective in some patients
***Bone marrow transplantation is currently the only potentially curative therapy for MDS patients.
Stem cell - Definition
A cell that has the ability to continuously divide and differentiate into various other kind(s) of cells/tissues.
Embryonic stem cells
come from a five to six-day-old embryo. They have the ability to form virtually any type of cell found in the human body.
Adult stem cells
undifferentiated cells found among specialized or differentiated cells in a tissue or organ after birth. Based on current research they appear to have a more restricted ability to produce different cell types and to self-renew.
Embryonic germ cells
are derived from the part of a human embryo or fetus that will ultimately produce eggs or sperm (gametes).
Graft Sources
Allogeneic: from another person
Syngeneic: from an identical twin
Autologous: from the patient
Umbilical cord blood
Alternative Donors
Matched Unrelated Donors (MUD)
NMDP – Be The Match
Severe GVHD
Higher TRM
Haploidentical Donors
From parent, child or sibling
Must have many stem cells to overcome risk of graft rejection
Increased risk of GVHD
Allogeneic Transplants
High TRM (30-50%)
Lower relapse rates due to graft versus tumor effects
Graft versus host effects
Matched Related Donor (siblings)
25% chance a sibling will be a match
The more siblings a patient has the better chance for a match
Autologous Transplant
No evidence of disease in the blood or bone marrow
Transplant related mortality (TRM) lowest with autos (<5%)
Relapse rates are higher depending on the disease
Absence of graft versus host effects